Company Filing History:
Years Active: 2018-2021
Title: Johanna Husmark: Innovator in Cardiovascular Treatment
Introduction
Johanna Husmark is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of cardiovascular medicine, particularly through her innovative research and development of specific antibodies.
Latest Patents
Johanna holds 2 patents related to antibodies specific for LOX1 and their use in the treatment of cardiovascular disorders. Her latest patents disclose LOX1 binding proteins, such as anti-LOX1 antibodies, along with compositions and methods for creating these binding proteins. These LOX1-binding proteins are designed to inhibit or antagonize LOX1 activity. Furthermore, her disclosures provide valuable compositions and methods for diagnosing and treating various conditions associated with atherosclerosis, thrombosis, coronary artery disease (CAD), ischemia, myocardial infarction, acute coronary syndrome (ACS), stroke, reperfusion injury, restenosis, peripheral vascular disease, hypertension, heart failure, chronic inflammation, angiogenesis, preeclampsia, cancer, and other LOX1-mediated diseases and conditions.
Career Highlights
Johanna is currently associated with Medimmune Limited, where she continues to advance her research in the field of cardiovascular disorders. Her work has been instrumental in developing therapeutic strategies that target critical health issues.
Collaborations
Johanna has collaborated with notable colleagues, including Andrew Grier Buchanan and Matthieu Chodorge, to further enhance her research and innovation in the medical field.
Conclusion
Johanna Husmark's contributions to cardiovascular treatment through her innovative patents and research are commendable. Her work continues to pave the way for advancements in medical therapies that address significant health challenges.